RT @PADeCI1: El Dr. Alarid-Escudero (@feralaes), Natalia R. Kunst, A. David Paltiel y Shi-Yi Wang desarrollaron un análisis de valor de la…
RT @PADeCI1: El Dr. Alarid-Escudero (@feralaes), Natalia R. Kunst, A. David Paltiel y Shi-Yi Wang desarrollaron un análisis de valor de la…
El Dr. Alarid-Escudero (@feralaes), Natalia R. Kunst, A. David Paltiel y Shi-Yi Wang desarrollaron un análisis de valor de la información para poder realizar un análisis de costo-efectividad del uso de 21-GA en el tratamiento de #cáncerdemama. https://t.co
RT @NataliaKunst: @eKrijkamp Haha! Thanks, @eKrijkamp! It was my paper on #ValueOfInformation of research on the 21-gene assay, with my ama…
@eKrijkamp Haha! Thanks, @eKrijkamp! It was my paper on #ValueOfInformation of research on the 21-gene assay, with my amazing co-authors @feralaes @ADPaltiel @shiyijjwang 🌟 #MedTwitter #phdlife #phdlife https://t.co/3xSr9ItoJC
RT @louisagord: Excellent article saying the 21-Gene Assay for early stage breast cancer management is worthwhile for intermediate and high…
@AnkurFactorial @altonrus @ConVOIgroup @socmdm I presented #VOI application here: https://t.co/3xSr9ItoJC In our study, RCT had the greatest potential to efficiently reduce decision uncertainty but the other obs also had pos marginal benefits. In other ca
RT @NataliaKunst: I'm thrilled to see that our recent #ValueOfInformation paper in @ISPORJournals was selected Editor's Choice and given Op…
RT @eKrijkamp: No excuses not to read this anymore. Absolutely, great work from the @ConVOIgroup. Great choice @ISPORJournals. https://t.co…
RT @NataliaKunst: I'm thrilled to see that our recent #ValueOfInformation paper in @ISPORJournals was selected Editor's Choice and given Op…
RT @NataliaKunst: I'm thrilled to see that our recent #ValueOfInformation paper in @ISPORJournals was selected Editor's Choice and given Op…
RT @eKrijkamp: No excuses not to read this anymore. Absolutely, great work from the @ConVOIgroup. Great choice @ISPORJournals. https://t.co…
RT @NataliaKunst: I'm thrilled to see that our recent #ValueOfInformation paper in @ISPORJournals was selected Editor's Choice and given Op…
No excuses not to read this anymore. Absolutely, great work from the @ConVOIgroup. Great choice @ISPORJournals.
RT @NataliaKunst: I'm thrilled to see that our recent #ValueOfInformation paper in @ISPORJournals was selected Editor's Choice and given Op…
RT @NataliaKunst: I'm thrilled to see that our recent #ValueOfInformation paper in @ISPORJournals was selected Editor's Choice and given Op…
RT @NataliaKunst: I'm thrilled to see that our recent #ValueOfInformation paper in @ISPORJournals was selected Editor's Choice and given Op…
RT @NataliaKunst: I'm thrilled to see that our recent #ValueOfInformation paper in @ISPORJournals was selected Editor's Choice and given Op…
RT @NataliaKunst: I'm thrilled to see that our recent #ValueOfInformation paper in @ISPORJournals was selected Editor's Choice and given Op…
RT @NataliaKunst: I'm thrilled to see that our recent #ValueOfInformation paper in @ISPORJournals was selected Editor's Choice and given Op…
RT @NataliaKunst: I'm thrilled to see that our recent #ValueOfInformation paper in @ISPORJournals was selected Editor's Choice and given Op…
I'm thrilled to see that our recent #ValueOfInformation paper in @ISPORJournals was selected Editor's Choice and given Open Access status at no charge! We like Open Access, especially when it's free! A huge thank you to Value in Health' Editors-in-Chief!
RT @NataliaKunst: I am glad that you found our #valueofinformation article in @ISPORJournals interesting, @louisagord! #healtheconomics #d…
RT @gianlubaio: Good stuff from ConVOI friends (https://t.co/NnjQNvQWJn) A Value of Information Analysis of Research on the 21-Gene Assay…
RT @gianlubaio: Good stuff from ConVOI friends (https://t.co/NnjQNvQWJn) A Value of Information Analysis of Research on the 21-Gene Assay…
RT @louisagord: Excellent article saying the 21-Gene Assay for early stage breast cancer management is worthwhile for intermediate and high…
RT @louisagord: Excellent article saying the 21-Gene Assay for early stage breast cancer management is worthwhile for intermediate and high…
I am glad that you found our #valueofinformation article in @ISPORJournals interesting, @louisagord! #healtheconomics #decisionmaking #PrecisionMedicine #HEOR #valueofinformation @ISPORorg
RT @gianlubaio: Good stuff from ConVOI friends (https://t.co/NnjQNvQWJn) A Value of Information Analysis of Research on the 21-Gene Assay…
RT @gianlubaio: Good stuff from ConVOI friends (https://t.co/NnjQNvQWJn) A Value of Information Analysis of Research on the 21-Gene Assay…
RT @gianlubaio: Good stuff from ConVOI friends (https://t.co/NnjQNvQWJn) A Value of Information Analysis of Research on the 21-Gene Assay…
Excellent article saying the 21-Gene Assay for early stage breast cancer management is worthwhile for intermediate and high risk women but more research needed in low risk women. @ISPORorg #breastcancer #healtheconomics https://t.co/SySg5TPYxl
Good stuff from ConVOI friends (https://t.co/NnjQNvQWJn) A Value of Information Analysis of Research on the 21-Gene Assay for Breast Cancer Management https://t.co/0gnwU8Z0Qv
RT @YaleCDE: New paper from @YaleCDE Associate Professor @shiyijjwang and colleagues: A value of information analysis of research on the 21-gene assay for breast cancer management. Read it here: https://t.co/sEUvKNWjN6 #BreastCancerResearch
New paper from @YaleCDE Associate Professor @shiyijjwang and colleagues: A value of information analysis of research on the 21-gene assay for breast cancer management. Read it here: https://t.co/oV5IkZdjwF
I'd love to do exactly these type of analyses... I have so many ideas, I just have to find the time to code them 😭
RT @NataliaKunst: In our new study @ISPORorg, we quantified the value of further research on the use of 21-gene assay in #breastcancer, and…
RT @NataliaKunst: In our new study @ISPORorg, we quantified the value of further research on the use of 21-gene assay in #breastcancer, and…
RT @NataliaKunst: In our new study @ISPORorg, we quantified the value of further research on the use of 21-gene assay in #breastcancer, and…
RT @NataliaKunst: In our new study @ISPORorg, we quantified the value of further research on the use of 21-gene assay in #breastcancer, and…
RT @NataliaKunst: In our new study @ISPORorg, we quantified the value of further research on the use of 21-gene assay in #breastcancer, and…
Check out @NataliaKunst quite impressive and high quality study quantifying the value of potential future research in #PrecisionMedicine for #breastcancer 👇🏽
RT @NataliaKunst: In our new study @ISPORorg, we quantified the value of further research on the use of 21-gene assay in #breastcancer, and…
In our new study @ISPORorg, we quantified the value of further research on the use of 21-gene assay in #breastcancer, and showed how #VOI can inform #decisionmaking for #precisionmedicine, providing information on future research and optimal study designs:
#HealthEconJA A Value of Information Analysis of Research on the 21-Gene Assay for Breast Cancer Management https://t.co/IYrLMlNIKW